KUALA LUMPUR (Dec 23): Southern Score Builders Bhd's (KL:SSB8) proposed acquisition of Nova Pharma Solutions (NPS) is expected to lift group earnings, citing the deal’s attractive valuation and earnings accretion. Analysts estimate the acquisition could lift Southern Score’s profit attributable to shareholders in the next three and a half years, depending on the final shareholding following the mandatory takeover offer. Southern Score's financial year ends on June 30. Beyond the near-term uplift, the deal is seen as strategically positive, as Nova Pharma’s specialised pharmaceutical and biotechnology engineering capabilities would allow Southern Score to access higher-margin, regulated projects. Separately, Phillip Research said Southern Score’s outstanding order book stood at RM1.6 billion, equivalent to 7.2 times FY2025 revenue, supported by sustained momentum in data centre projects, which make up about 19% of the group’s order book.

Source: The Edge Markets December 23, 2025 04:51 UTC